Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 single- and multiple-ascending-dose study of LAS191954 in healthy male volunteers
NL-OMON42989Phase 1Active, not recruiting
- Sponsor
- Almirall
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in pemphigus vulgaris (PV) comparing LAS191954 with Placebo (2 arms). Primary endpoints: Safety and tolerability, Pharmacokinetics and 1 more. Started May 2016; status: active, not recruiting.
02
Drugs
LAS191954
03
Conditions
pemphigus vulgaris (PV)
Beyond the preview
Go deeper on NL-OMON42989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42989.